Acemoglu, D., and S. Johnson. 2007. Disease and Development: The Effect of Life Expectancy on Economic Growth. Journal of Political Economy, 115(6): 92585.
- American Heart Association. 2005. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX.
Paper not yet in RePEc: Add citation now
- Antonopoulos, 5. 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106: 3143-421.
Paper not yet in RePEc: Add citation now
- Arnett, D. K., P. G McGovern, D. R. Jacobs Jr, E. Shahar, S. Duval, H. Blackburn, and R. V. Luepker. 2002. Fifteen-year Trends in Cardiovascular Risk Factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am. J. Epidemiol., 156:929-35.
Paper not yet in RePEc: Add citation now
- Arnett, Donna K., David R. Jacobs, Russell V. Luepker, Henry Blackburn, Christopher Armstrong, and Steven A. Claas. 2005. Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use The Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation, 112: 388491.
Paper not yet in RePEc: Add citation now
- Atella, V., and the TECH Investigators. 2003. The Relationship between Health Policies, Medical Technology Trend, and Outcomes: A Perspective from the TECH Global Research Network in What is Best and at What Cost: A Disease-Based Approach to Comparing Health Systems, OECD, Paris, France.
Paper not yet in RePEc: Add citation now
- Atella, V., F. Belotti, F. D'Amico, A. Catapano, C. Cortese, and C. Cricelli. 2009. Can Better Drug Treatment Improve Long-Run Financial Sustainability of NHS in Italy? The Case of Statins. CEIS Research Paper, CEIS Tor Vergata, Rome.
Paper not yet in RePEc: Add citation now
Atella, V., F. Peracchi, D. Depalo, and C. Rossetti. 2006. Drug Compliance, CoPayment, and Health Outcomes: Evidence from a Panel of Italian Patients. Health Economics 15: 875-92.
- British Heart Foundation Statistics Database. 2005. Coronary Heart Disease Statistics http://www.heartstats.org (last access on October 2009).
Paper not yet in RePEc: Add citation now
- Cutler D. M., and M. McClellan. 2001. Is Technological Change in Medicine Worth It? Health Affairs, 25(2): 34-47.
Paper not yet in RePEc: Add citation now
- Cutler, D. M., A. B. Rosen, and S.Vijan. 2006. The Value of Medical Spending in the United States, 1960-2000. The New England Journal of Medicine 355(9): 920.
Paper not yet in RePEc: Add citation now
- Eliasson, M., U. Janlert, J.-H. Jansson, and B. Stegmayr. 2006. Time Trends in Population Cholesterol Levels 1986-2004: Influence of Lipid-Lowering Drugs, Obesity, Smoking and Educational Level. The Northern Sweden MONICA Study. Journal of Internal Medicine, 260: 551-59.
Paper not yet in RePEc: Add citation now
- EUROASPIRE II. 2001. Lifestyle and Risk Factor Management and Use of Drug Therapies in Coronary Patients from 15 Countries. Principal Results from EUROASPIRE II Euro Heart Survey Programme, European Heart Journal, 22: 554-72.
Paper not yet in RePEc: Add citation now
- Fabiani, L., M. Scatigna, K. Panopoulou, A. Sabatini, E. Sessa, F. Donato, M. Marchi, et al. 2004. Health Search: istituto di ricerca della societâ italiana di medicina generale; la realizzazione di un database per la ricerca in medicina generale. Epidemiol. &Prev. 28: 156-62.
Paper not yet in RePEc: Add citation now
- Federman, A. D., S. A. Alyce, D. Ross-Degnan, S. B. Sourmerai, and J. Z. Ayanina. 2001. Supplemental Insurance and Use of Elective Cardiovascular Drugs among Elderly Medicare Beneficiaries with Coronary Heart Disease. JAMA 286(14): 1732-39.
Paper not yet in RePEc: Add citation now
- Ford, E. S., A. H. Mokdad, W. H. Giles, and G. A. Mensah. 2003. Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia among US Adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003(107): 2 185-89.
Paper not yet in RePEc: Add citation now
- Giampaoli, S., L. Palmieri, A. Mattiello, and S. Panico. 2005. Definition of High Risk Individuals to Optimise Strategies for Primary Prevention of Cardiovascular Diseases Nutr Metab. Cardiovasc. Dis. 15: 79-85.
Paper not yet in RePEc: Add citation now
Gowrisankaran, G., and R. J. Town. 2004. Managed Care, Drug Benefit and Mortality: An Analysis of the Elderly. NBER Working Papers, No. 10204, National Bureau of Economic Research, Boston, MA.
Grootendorst P., E. Piérard, and M. Shim. 2007. The Life Expectancy Gains from Pharmaceutical Drugs: A Critical Appraisal of the Literature, SEDAP Research Paper No. 221, McMaster University, Hamilton, Ontario, Canada Grossman, M. 1972. The Demand for Health: A Theoretical and Empirical Investigation. National Bureau of Economic Research. New York: Columbia University Press.
- Gurmankin, A. D., J. Baron, J. C. Hershey, and P. A. Ubel. 2002. The Role of Physicians' Recommendations in Medical Treatment Decisions. Medical Decision Making 22(3): 262-71.
Paper not yet in RePEc: Add citation now
- Hyman, D. J., V. N. Pavlik, and C. Vallbona. 2000. Physician Role in Lack of Awareness and Control of Hypertension. J. Clin. Hypertens. 2(5): 324-30.
Paper not yet in RePEc: Add citation now
- Johansson, E., V. K. Diwana, N. D. Huongb, and B. M. Ahlberga. 1996. Staff and Patient Attitudes to Tuberculosis and Compliance with Treatment: An Exploratory Study in a District in Vietnam. Tubercle and Lung Disease, 77(April):178-83.
Paper not yet in RePEc: Add citation now
Jones, Charles I. 2005. More Life vs. More Goods: Explaining Rising Health Expenditures. FRBSF Economic Letter 2005-10 (May 27).
Lichtenberg, F. R. 1996. Do (More and Better) Drugs Keep People Out of Hospitals?, The American Economic Review 86(2): 384-88.
Lichtenberg, F. R. 2007. Pharmaceutical Innovation and U.S. Cancer Survival, 19922003: Evidence from Linked SEER-MEDSTAT Data. Forum for Health Economics & Policy 10(1).
Lichtenberg, F. R. 2008. Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence from Longitudinal Country-Level Data on 20 OECD countries 1995-2003, NBER Working Papers, No. 14008, National Bureau of Economic Research.
- Long G., D. M. Cutler, and E. R. Berndt. 2007. The Value of Antihypertensive Drugs : A Perspective on the Value of Improved Blood Pressure Control in the USA. European Heart Journal Supplements 9, Suppl. B.
Paper not yet in RePEc: Add citation now
- McClellan, M., and D. Kessler. 1999. A Global Analysis of Technological Change in Health Care: The Case of Heart Attacks. Health Affairs 18(3): 250-55.
Paper not yet in RePEc: Add citation now
- McClellan, M.B., and D. P. Kessler. 2002. Technological Change in Health Care. A Global Analysis of Heart Attack. Ann Arbor, MI: The University of Michigan Press.
Paper not yet in RePEc: Add citation now
- McCombs, J., P. Thiebaud, C. McLaughlin-Miley, and J. Shi. 2004. Compliance with Drug Therapies for the Treatment and Prevention of Osteoporosis. Maturitas 48(3): 271-87.
Paper not yet in RePEc: Add citation now
Murphy, K. M., and R. H. Topel. 2006. The Value of Health and Longevity. Journal of Political Economy 114(5): 871-904.
- Muurinen, Jaana-Marja. 1982. A Generalised Grossman Model. Journal of Health Economics 1: 5-28.
Paper not yet in RePEc: Add citation now
- Pearson, T.A., I. Laurora, H. Chu, and S. Kafonek. 2000. The Lipid Treatment Assessment Proj ect (L-TAP): A Multicenter Survey to Evaluate the Percentages of Dyslipidemic Patients Receiving Lipid-Lowering Therapy and Achieving Low-Density Lipoprotein Cholesterol Goals. Arch. Intern. Med. 28;160(4): 459-67.
Paper not yet in RePEc: Add citation now
- Ruiz, F. J. G., A. M. Ibáflez, F. Perez-Jimenez, X. Pinto, G. Nocea, C. Ahumada, et al. 2004. Current Lipid Management and Low Cholesterol Goal Attainment in Common Daily Practice in Spain: The REALITY Study. Pharmacoeconomics 22: 1.
Paper not yet in RePEc: Add citation now
- Sedgley, M., and T. Hockley. 2006. A Comprehensive Review of the Existing Literature on Cholesterol Management, in Cholesterol: The Public Policy Implications of Not Doing Enough, Stockholm Network, Stockholm.
Paper not yet in RePEc: Add citation now
- Sessa, E., F. Samani, C.Niccolai, S. Pecchioli, G. Ventriglia, and G Mazzaglia. 2004. La creazione di un campione validato di Medici di Medicina Generale nel database di Health Search. SIMG 3: 10-14.
Paper not yet in RePEc: Add citation now
- Soumerai, S. B., D. Ross-Degnan, J. Avorn, T. J. McLaughlin, and I. Choodnovskiy. 1991. Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes. New England Journal of Medicine 325: 1072-77.
Paper not yet in RePEc: Add citation now
- Soumerai, S. B., T. J. McLaughlin, D. Ross-Degnan, C. S. Casteris, and P. Bollini. 1991. Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia. New England Journal of Medicine 331: 650-55.
Paper not yet in RePEc: Add citation now
- Tamblyn, R., R. Laprise, J. A. Hanley, M. Abrahamowicz, S. Scott, N. Mayor, et al. 2001. Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons. JAMA 285(4): 421-29.
Paper not yet in RePEc: Add citation now
- Unal, B., J.A. Critchley, and S. Capewell. 2004. Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000, Circulation 109:1101-7.
Paper not yet in RePEc: Add citation now
Valletta, R. 2007. The Costs and Value of New Medical Technologies: Symposium Summary, FRBSF Economic Letter, Number 2007-18, July 6, 2007.
- Weisfeldt, M.L., and S.J. Zieman. 2007. Advances in the Prevention and Treatment of Cardiovascular Disease. Health Affairs 26(1): 25-37.
Paper not yet in RePEc: Add citation now
- Wooldridge, J.M. 2002. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press.
Paper not yet in RePEc: Add citation now
Yang, Z., D. B. Gilleskie, and E. C. Norton. 2009. Health Insurance, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics. Journal of Human Resources 44(1): 47-114.